Editas Medicine, Inc. (EDIT)
Since May 05, 2021, Editas Medicine, Inc. (EDIT) has reported earnings 21 times. On average the shares move ±10.22% post-earnings, with a positive reaction 76.2% of the time. Its largest post-earnings gain was +34.5% (Aug 12, 2025) and its largest decline was -13.17% (Mar 05, 2025). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±10.22%
Positive %
76.2%
Negative %
23.8%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 05, 2026 | ☀ PRE | $3.12 | $3.16 | $3.04 | 71,890 | +0.83% | open_in_new |
| Mar 09, 2026 | ☀ PRE | $1.98 | $2.47 | $2.32 | 4,948,200 | +16% | open_in_new |
| Nov 10, 2025 | ☀ PRE | $2.71 | $2.71 | $2.52 | 2,285,300 | +2.02% | open_in_new |
| Aug 12, 2025 | ☽ POST | $2.22 | $2.33 | $2.29 | 1,287,600 | +34.5% | open_in_new |
| May 12, 2025 | ☽ POST | $1.55 | $1.76 | $1.54 | 3,340,100 | -2.6% | open_in_new |
| Mar 05, 2025 | ☽ POST | $1.85 | $2.25 | $2.05 | 9,165,600 | -13.17% | open_in_new |
| Nov 04, 2024 | ☀ PRE | $2.90 | $3.08 | $2.88 | 3,952,000 | -1.03% | open_in_new |
| Aug 07, 2024 | ☀ PRE | $4.88 | $4.90 | $4.11 | 3,081,100 | -12.18% | open_in_new |
| May 08, 2024 | ☀ PRE | $5.40 | $5.40 | $5.04 | 4,346,900 | -11.36% | open_in_new |
| Feb 28, 2024 | ☀ PRE | $10.24 | $11.58 | $11.07 | 7,179,800 | +24.94% | open_in_new |
| Nov 03, 2023 | ☀ PRE | $7.25 | $8.75 | $8.31 | 4,107,300 | +18.21% | open_in_new |
| Aug 02, 2023 | ☀ PRE | $8.50 | $9.52 | $9.14 | 2,848,500 | +5.66% | open_in_new |
| May 05, 2023 | ☀ PRE | $8.94 | $10.52 | $9.77 | 4,447,900 | +12.04% | open_in_new |
| Feb 22, 2023 | ☀ PRE | $9.46 | $9.95 | $9.75 | 2,069,400 | +6.21% | open_in_new |
| Nov 02, 2022 | ☀ PRE | $12.95 | $14.23 | $12.89 | 2,284,400 | +1.1% | open_in_new |
| Aug 03, 2022 | ☀ PRE | $17.54 | $19.40 | $18.69 | 3,093,400 | +13.41% | open_in_new |
| May 04, 2022 | ☀ PRE | $14.35 | $15.94 | $15.81 | 1,692,700 | +11.5% | open_in_new |
| Feb 24, 2022 | ☀ PRE | $13.27 | $16.01 | $15.86 | 2,723,400 | +10.06% | open_in_new |
| Nov 08, 2021 | ☀ PRE | $37.75 | $42.08 | $40.57 | 2,667,800 | +8.19% | open_in_new |
| Aug 04, 2021 | ☀ PRE | $41.34 | $46.18 | $46.05 | 2,073,600 | +9.36% | open_in_new |
| May 05, 2021 | ☀ PRE | $35.00 | $36.87 | $34.72 | 1,386,900 | +0.17% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±10.22%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260603 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260603 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260602 | open_in_new SEC.gov |
| 144 | 20260529 | open_in_new SEC.gov |
| 424B5 | 20260526 | open_in_new SEC.gov |
| 424B5 | 20260526 | open_in_new SEC.gov |
| 8-K | 20260526 | open_in_new SEC.gov |
Frequently asked about EDIT earnings
When does Editas Medicine, Inc. report earnings next? expand_more
Editas Medicine, Inc. (EDIT)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does EDIT stock move after earnings? expand_more
Over 21 reports, EDIT has moved an average of ±10.22% the session after earnings, closing higher 76.2% of the time.
What was EDIT's biggest post-earnings move? expand_more
EDIT's largest post-earnings gain on record was +34.5% on Aug 12, 2025, and its largest decline was -13.17% on Mar 05, 2025.
Where can I find Editas Medicine, Inc.'s SEC filings? expand_more
All of Editas Medicine, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right